Alyeska Investment Group
NH

Alyeska Investment Group’s NantHealth, Inc NH Stock Holding History

Alyeska Investment Group’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-19,821
Closed -$907K – 551
2018
Q1 		$907K Sell
19,821
-16,414
-45% -$824K 0.01% 395
2017
Q4 		$1.66M Hold
36,235
– – 0.01% 351
2017
Q3 		$2.24M Buy
36,235
+647
+2% +$37.9K 0.02% 352
2017
Q2 		$2.26M Sell
35,588
-1,079
-3% -$59.8K 0.02% 344
2017
Q1 		$2.73M Hold
36,667
– – 0.02% 372
2016
Q4 		$5.47M Hold
36,667
– – 0.05% 317
2016
Q3 		$7.23M Hold
36,667
– – 0.07% 304
2016
Q2 		$6.88M Buy
+36,667
New +$7.99M 0.06% 283

Other funds holding NH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group's NH Position: Q2 2018 in Review

Alyeska Investment Group sold out of NantHealth, Inc (NH) in Q2 2018, closing a stake of 19,821 shares — an estimated $907K sold.

Alyeska Investment Group first reported a position in NH in Q2 2016 and held it in 8 quarters. The position peaked at $7.23M in Q3 2016. 49 funds tracked by Wall St. Rank hold NH as of Q2 2018.

  • Alyeska Investment Group reported no remaining NantHealth, Inc position as of Q2 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 19,821 NantHealth, Inc shares in Q2 2018, an estimated $907K.
  • Alyeska Investment Group first reported a position in NantHealth, Inc in Q2 2016 and held it in 8 quarters.
  • Alyeska Investment Group's NantHealth, Inc position peaked at $7.23M in Q3 2016.
  • 49 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2018.

Based on Alyeska Investment Group's 13F filing for Q2 2018, filed 14 Aug 2018.